Trial intelligence / Profile preview

Vitamin B12 eye drops for myopia progression in children

ChiCTR1800016504Phase 4Recruiting

Sponsor
Jiangsu Provincial People's Hospital
Start
Jul 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of cyanocobalamin in myopia (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Diopter. Started Jul 2018; status: recruiting.

02

Drugs

cyanocobalamin
03

Conditions

myopia

Beyond the preview

Go deeper on ChiCTR1800016504.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800016504.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call